Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

Market Cap	5.82B +4.7%
Revenue (ttm)	827.14M +6.8%
Net Income	65.09M -15.2%
EPS	0.16 -15.1%
Shares Out	417.60M
PE Ratio	89.35
Forward PE	n/a
Dividend	0.10 (0.72%)
Ex-Dividend Date	n/a

Volume	2,118,122
Average Volume	4,539,478
Open	13.80
Previous Close	13.90
Day's Range	13.71 - 14.04
52-Week Range	12.84 - 22.69
Beta	-0.08
RSI	46.23
Earnings Date	Apr 24, 2026

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 1,384
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002907

Financial Performance

In 2025, SHE:002907's revenue was 827.14 million, an increase of 6.75% compared to the previous year's 774.82 million. Earnings were 65.09 million, a decrease of -15.17%.